Curaleaf and The Baldwin Fund Partner to Raise Funds for Breast Cancer Research This October

Core Points - Curaleaf is celebrating the sixth year of its national at-register donation program for Breast Cancer Action Month, partnering with The Baldwin Fund to support breast cancer research [1][2] - The Baldwin Fund has raised over $13 million for breast cancer research and is launching a $50 million campaign to achieve National Cancer Institute designation for the Upstate Cancer Center [2][7] - Curaleaf's initiative allows customers to "Round Up for Research" at checkout, with proceeds going to lifesaving research at Upstate Medical University [1][3] Company Overview - Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, known for its commitment to quality and community [5][6] - The company operates a strong distribution network across Europe, Canada, and Australasia, integrating science and research with cultivation and production [6] - Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF [6] Community Engagement - The partnership with The Baldwin Fund allows Curaleaf to enhance its impact nationwide, uniting customers and communities in the fight against breast cancer [2][3] - Curaleaf recognizes Breast Cancer Action Month as an opportunity to honor those affected by breast cancer and to support research efforts [3][4] - The initiative is available at the majority of Curaleaf's retail locations across 13 states, including Arizona, Connecticut, Florida, and New York [4]